Chronic Kidney Disease News

A new initiative seeks to offer treatment for depression inside the dialysis clinic for patients with both conditions. The program will launch in February of 2024 across four states.

Interwell Health has signed an agreement with health care provider Humana Inc. to provide care to patients with chronic kidney disease in 13 states.

Underrepresented groups with kidney disease face greater health care burdens due to psychological and structural factors, such as stigma and institutional racism, data show.

Living conditions in the southeastern region of the United States, known as the “stroke belt” for its higher incidence of stroke among the population, pose a novel risk of chronic kidney disease, a recently published study shows.

HHS announced the first 10 drugs that will be subject to Medicare price negotiations.

A short course of inorganic dietary nitrate reduced contrast-induced kidney injury in high-risk patients with non-ST segment elevation ACS referred for invasive coronary angiography, researchers reported.

Psychological distress may be linked to poor self-management of chronic kidney disease, according to a recently published study of patients with CKD who were not on dialysis.

Moderate to severe pruritus remains a chronic problem in patients on maintenance hemodialysis that can reduce overall quality of life, according to recently published data.

Blood tests showed that canagliflozin plus standard care lowered biomarkers levels associated with chronic kidney disease and CVD events in patients with diabetes and albuminuria vs. placebo, researchers reported.

The FDA has granted priority review status for the supplemental new drug application of Tarpeyo delayed-release capsules.